PDSBPDS Biotechnology Corp
- Market cap
- $80.45M
- as of 2026-10-23
- Latest close
- $1.11
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-04
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Dawson John Andrew | Oct 18 | Oct 21 | A · derivative | 22,700 | $1.13 | $25,651 | 22,700 | No | Form 4 |
| Ramsdell Deborah | Oct 18 | Oct 20 | A · derivative | 22,700 | $1.13 | $25,651 | 22,700 | No | Form 4 |
| Wendel Bruce | Oct 18 | Oct 20 | A · derivative | 22,700 | $1.13 | $25,651 | 22,700 | No | Form 4 |
| Glover Stephen C. | Jan 12 | Mar 3 | A · derivative | 54,876 | $0.98 | $53,778 | 54,876 | No | Form 4 |
| Brawley Otis W | Jan 12 | Mar 3 | A · derivative | 54,876 | $0.98 | $53,778 | 54,876 | No | Form 4 |
| Ali-Jackson Kamil | Jan 12 | Mar 3 | A · derivative | 54,876 | $0.98 | $53,778 | 54,876 | No | Form 4 |
| Iliev Ilian | Jan 12 | Mar 3 | A · derivative | 54,876 | $0.98 | $53,778 | 54,876 | No | Form 4 |
| Freitag Gregory Gene | Jan 12 | Mar 3 | A · derivative | 54,876 | $0.98 | $53,778 | 54,876 | No | Form 4 |
| Toutain StephanChief Operating Officer | Jan 12 | Mar 3 | A · derivative | 300,000 | $0.98 | $294,000 | 300,000 | No | Form 4 |
| Brown Spencer D.Senior VP, General Counsel | Jan 12 | Mar 3 | A · derivative | 300,000 | $0.98 | $294,000 | 300,000 | No | Form 4 |
| Boesgaard LarsChief Financial Officer | Jan 12 | Mar 3 | A · derivative | 300,000 | $0.98 | $294,000 | 300,000 | No | Form 4 |
| Shepard Kirk V.Chief Medical Officer | Jan 12 | Mar 3 | A · derivative | 300,000 | $0.98 | $294,000 | 300,000 | No | Form 4 |
| Conn GregoryChief Scientific Officer | Jan 12 | Mar 3 | A · derivative | 150,000 | $0.98 | $147,000 | 150,000 | No | Form 4 |
| Bedu-Addo FrankPresident/CEO | Jan 12 | Mar 3 | A · derivative | 548,782 | $0.98 | $537,806 | 548,782 | No | Form 4 |
| Toutain StephanChief Operations Officer | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 150,000 | $1.79 | $268,500 | 150,000 | No | Form 4 |
| Conn GregoryChief Scientific Officer | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 40,000 | $1.79 | $71,600 | 40,000 | No | Form 4 |
| Boesgaard LarsChief Financial Officer | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 150,000 | $1.79 | $268,500 | 150,000 | No | Form 4 |
| Brown Spencer D.Senior VP, General Counsel | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 150,000 | $1.79 | $268,500 | 150,000 | No | Form 4 |
| Shepard Kirk V.Chief Medical Officer | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 150,000 | $1.79 | $268,500 | 150,000 | No | Form 4 |
| Bedu-Addo FrankPresident/CEO | Jun 12, 2025 | Jul 25, 2025 | A · derivative | 150,000 | $1.79 | $268,500 | 150,000 | No | Form 4 |
| Conn GregoryChief Scientific Officer | Feb 28, 2024 | Jul 25, 2025 | A · derivative | 46,648 | $5.87 | $273,824 | 46,648 | No | Form 4 |
| Brown Spencer D.Senior VP, General Counsel | Feb 28, 2024 | Jul 25, 2025 | A · derivative | 56,000 | $5.87 | $328,720 | 56,000 | No | Form 4 |
| Bedu-Addo FrankPresident/CEO | Feb 28, 2024 | Jul 25, 2025 | A · derivative | 300,000 | $5.87 | $1,761,000 | 300,000 | No | Form 4 |
| Glover Stephen C. | Jun 11, 2025 | Jun 11, 2025 | A · derivative | 22,700 | $1.75 | $39,725 | 22,700 | No | Form 4 |
| Freitag Gregory Gene | Jun 11, 2025 | Jun 11, 2025 | A · derivative | 22,700 | $1.75 | $39,725 | 22,700 | No | Form 4 |
| Ali-Jackson Kamil | Jun 11, 2025 | Jun 11, 2025 | A · derivative | 22,700 | $1.75 | $39,725 | 22,700 | No | Form 4 |
| Iliev Ilian | Jun 11, 2025 | Jun 11, 2025 | A · derivative | 22,700 | $1.75 | $39,725 | 22,700 | No | Form 4 |
| Brawley Otis W | Jun 11, 2025 | Jun 11, 2025 | A · derivative | 22,700 | $1.75 | $39,725 | 22,700 | No | Form 4 |
| Glover Stephen C. | Feb 28, 2025 | Mar 3, 2025 | P | 15,061 | $1.66 | Purchase +$25,001 | 78,851 | No | Form 4 |
| Glover Stephen C. | Feb 28, 2025 | Mar 3, 2025 | P · derivative | 15,061 | $1.53 | Purchase +$23,043 | 15,061 | No | Form 4 |
| Freitag Gregory Gene | Feb 28, 2025 | Mar 3, 2025 | P | 15,060 | $1.66 | Purchase +$25,000 | 61,213 | No | Form 4 |
| Freitag Gregory Gene | Feb 28, 2025 | Mar 3, 2025 | P · derivative | 15,060 | $1.53 | Purchase +$23,042 | 15,060 | No | Form 4 |
| Ali-Jackson Kamil | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Brawley Otis W | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Iliev Ilian | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Sykes Richard | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Glover Stephen C. | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Freitag Gregory Gene | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 9,000 | $2.86 | $25,740 | 9,000 | No | Form 4 |
| Toutain StephanChief Operations Officer | May 1, 2024 | May 2, 2024 | A · derivative | 200,000 | $3.61 | $722,000 | 200,000 | No | Form 4 |
| Shepard Kirk V.Chief Medical Officer | Jan 22, 2024 | Jan 23, 2024 | A · derivative | 200,000 | $4.49 | $898,000 | 200,000 | No | Form 4 |
| Boesgaard LarsChief Financial Officer | Dec 4, 2023 | Dec 4, 2023 | A · derivative | 200,000 | $5.28 | $1,056,000 | 200,000 | No | Form 4 |